Keyphrases
Opiate Abuse
100%
Central Nervous System
100%
Neuropeptide FF
100%
Abstinence Syndrome
66%
Chemical Delivery System
55%
Metabolic Changes
22%
Morphine Abstinence
22%
Naloxone
22%
Functional Groups
22%
Desaminotyrosine
22%
Bioactivation
11%
Metabolic Properties
11%
Peptide Antagonist
11%
Structure-based Design
11%
Distribution Studies
11%
Octapeptide
11%
Brain Tissue
11%
Opiate Dependence
11%
N-alkylated
11%
Pharmacological Studies
11%
Tremor
11%
Morphine-dependent Mice
11%
Peptide Lipids
11%
Active Agent
11%
Nicotinamide
11%
Liposoluble Constituent
11%
Opioid Peptides
11%
Metabolic Stability
11%
System Distributions
11%
Biochemical Studies
11%
Peptide Amide
11%
Syndrome Metabolic
11%
Systems Approach
11%
New Drugs
11%
Anti-opioid
11%
In Vitro Stability
11%
Abstinence
11%
Lipids
11%
Pharmaceutical Study
11%
Systemic Administration
11%
Pharmacologically Active
11%
Blood-brain Barrier
11%
Ptosis
11%
Solid-phase Synthesis
11%
Metabolism Study
11%
Brain Targeting
11%
Polypeptide Chain
11%
Enzymatic Conversion
11%
Pharmacological Evaluation
11%
Attenuation
11%
Opiates
11%
Solution Synthesis
11%
Chatter
11%
Preclinical Development
11%
Stability Data
11%
Passive Transport
11%
Design Study
11%
Opioid Tolerance
11%
Opioid Dependence
11%
Sequential Metabolism
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropeptide FF
100%
Withdrawal Syndrome
100%
Opiate
100%
Morphine
50%
Lead Compound
33%
Naloxone
33%
Functional Groups
33%
Opiate Addiction
16%
Carboxamide
16%
Nicotinamide
16%
Systemic Administration
16%
Opiate Peptide
16%
Peptide
16%
Octapeptide
16%
Bioactivation
16%
Blood-Brain Barrier
16%